Application of response surface methodology to maximize the productivity of scalable automated human embryonic stem cell manufacture

Aim: Commercial regenerative medicine will require large quantities of clinical-specification human cells. The cost and quality of manufacture is notoriously difficult to control due to highly complex processes with poorly defined tolerances. As a step to overcome this, we aimed to demonstrate the u...

Full description

Saved in:
Bibliographic Details
Main Authors: Elizabeth Ratcliffe, Paul Hourd, Juan-Jose Guijarro-Leach, Erin Rayment, David Williams, Rob Thomas
Format: Default Article
Published: 2013
Subjects:
Online Access:https://hdl.handle.net/2134/13171
Tags: Add Tag
No Tags, Be the first to tag this record!